维普期刊资源整合服务平台（V6.5）

77篇 您的检索式：作者名="DeAngelo J"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	A tyrosine kinase created by fusion of the PDGRFRA and FIP1L1 genes as a thera- peutic target of imatinib in idiopathic hy- pereosinophilic syndrome 显示文摘	Cools J DeAngelo D J Gotlib J	2003	N Engl J Med2003，348，13：	1
2	PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder显示文摘	Chen J Deangelo DJ Kutok JL		0，，：	1
3	A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome 显示文摘	Cools J DeAngelo DJ Gotlib J	2003	N Engl J Med2003，348，13：	1
4	Accounting choice in troubled companies 显示文摘	DeAngelo H DeAngelo L Skinner D J	1994	Journal of Accounting and Economics1994，，1：	1
5	A tyrosine kinase created by fusion of the PDGFRA attd FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome显示文摘	Cools J DeAngelo DJ Gotlib J	2003	N Engl J Med2003，348，21：	1
6	Optimizing outcomes for patients with advanced disease in chronic mydogenous leukemia 显示文摘	Giles FJ DeAngelo D J Baccarani M	2008	Semin Oncol2008，35，1：	1
7	A tyrosine kinase created byfusion of the PDGFRA and FIP1L1 genes as a therapeutic target ofimatinib in idiopathic hypereosinophilic syndrome显示文摘	Cools J Deangelo DJ Gotlib J	2003	N Engl JMed2003，348，13：	1
8	Dividends and Losses 显示文摘	DEANGELO H DEANGELO L SKINNER D J	1992	Journal of Finance1992，47，5：	1
9	A tyrosine kinase created by fusion of the PDGFRA and FIPIL1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome显示文摘	COOLS J DEANGELO D J GOTLIB J	2003	N Engl J Med2003，348，：	1
10	Hereditary gingival fibro- matosis: A review显示文摘	DeAngelo S Murphy J Claman L	2007	Compend Contin Educ Dent2007，28，3：	1
11	Reversal of fortune:dividend singnaling and the disappearance of sustained earnings growth显示文摘	DEANGELO H DEANGELO L DOUGLAS J		0，，49：	1
12	Af-ter chronic myelogenous leukemia:tyrosine kinase inhibitorsin other hematologic malignancies显示文摘	WADLEIGH M DEANGELO D J GRIFFIN J D	2005	Blood2005，105，1：	1
13	Accounting Choices in Troubled Companies显示文摘	DENGELO H DEANGELO L SKINNER D J	1994	Journal of Accounting and Economics1994，17，12：	1
14	显示文摘	Cools J DeAngelo DJ Gotlib J	2003	N Engl J Med2003，348，：	1
15	Miocene chronostratigraphy,paleogeography and play frame- work of the Burgos Basin,southern Gulf of Mexico显示文摘	Hernandez-Mendoza J J Hentz T F DeAngelo M V	2008	AAPG Bulletin2008，92，11：	1
16	Are dividends disappearing? Dividend concentration and the consolidation of earnings显示文摘	DEANGELO H DEANGELO L SKINNER D J	2004	Journal of Financial Economics2004，72，3：	1
17	Phase IIB trial of oral Midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syn- drome with either wild-type or mutated FLT3 显示文摘	Fischer T Stone RM Deangelo D J	2010	J Clin Oncol2010，28，28：	1
18	Acute myeloid leukemia patients with an activating mutation in FLT3 respond to a small molecule FLT3 tyrosine kinase inhibitor,PKC412显示文摘	STONE R M DEANGELO D J KLIMEK V	2005	Blood2005，105，1：	1
19	Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: cancer and leukemia group B study 19801 显示文摘	Deangelo D J Yu D Johnson JL	2007	Blood2007，7，：	1
20	A first-in-human phase 1 study of the antibody-drug conjugate SGN-CD19A in relapsed or refractory B-lineage acute leukemia and highly aggressive lymphoma显示文摘	Fathi AT Shah BD Deangelo D J	2013	Blood2013，122，21：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示